Actively Recruiting
Higher vs. Lower Dose Heparin for PCI
Led by Population Health Research Institute · Updated on 2025-07-31
16000
Participants Needed
1
Research Sites
195 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
HD PCI is a multicenter, randomized, registry-based, cluster crossover design trial of higher dose versus lower dose heparin in patients undergoing elective percutaneous coronary intervention (PCI).
CONDITIONS
Official Title
Higher vs. Lower Dose Heparin for PCI
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients undergoing elective PCI
You will not qualify if you...
- Younger than 18 years
- Planned chronic total occlusion PCI
- Non-resident preventing follow-up through local registries
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Hamilton Health Sciences, General Hospital
Hamilton, Ontario, Canada, L8L 2X2
Actively Recruiting
Research Team
J
Jessica Tyrwhitt
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
CROSSOVER
Primary Purpose
PREVENTION
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here